Fexofenadin 180MG 500S
Ended Awarded Last action
- Contract number
- SPE2DR26FHYV6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,405
Award facts
- Contract value 100% obligated
- $1,404.85 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $1,404.85 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for 500 units of Fexofenadin 180mg, with an ultimate completion date of December 15, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. This delivery order was issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion Defense Logistics Agency acquisition strategy designed to streamline pharmaceutical supply chains for Department of Defense healthcare operations worldwide.
The delivery order represents a routine pharmaceutical supply requirement issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency, which carries a $499.999 billion ceiling value and extends through December 31, 2036. As an established prime vendor contractor within the PPV-G GEN V framework, DMS Pharmaceutical Group supplies a comprehensive range of pharmaceutical products including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals to support military healthcare facilities. The company has demonstrated substantial federal contracting activity through numerous delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division, positioning it as a critical supplier within the federal pharmaceutical distribution network.
Quick answers
Who was awarded contract SPE2DR26FHYV6?
SPE2DR26FHYV6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26FHYV6 worth?
The government has obligated $1,405 on SPE2DR26FHYV6.
Is contract SPE2DR26FHYV6 an order under another contract?
Yes. SPE2DR26FHYV6 is a delivery order under SPE2DR25D9762, an indefinite delivery contract.
Was contract SPE2DR26FHYV6 competed?
The extent of competition for SPE2DR26FHYV6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award